about
The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritisResistance of muscle to tumor metastases: a role for a3 adenosine receptor agonistsParoxysmal cold hemoglobinuria. Transmission and scanning electron microscopy features of erythrocytes.Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial.The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.Ciprofloxacin affects pregnancy loss in CBA/JxDBA/2J mice possibly via elevation of interleukin-3 and granulocyte macrophage-colony stimulating factor production.Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice.Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)Role of IL-3 in the antiphospholipid syndrome.Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data.Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial.SEM observations on Sendai virus-induced fusion of embryonic mouse erythroblasts.Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action.A3 adenosine receptor as a target for cancer therapy.The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways.IVIg to prevent tumor metastases (Review).Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsCF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.X-ray microanalysis of normal human neutrophils, lymphocytes, monocytes and platelets.Severe alterations of red blood cells from the vessels of colorectal tumors.Scanning and transmission electron microscopy study on the plasma cells of a patient with multiple myeloma.CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study.Effect of diclofenac-sodium (Voltaren) on the electrical charge of human platelet membrane.Auto-rosette formation in the peripheral blood of a patient with infectious mononucleosis.Satellitism of platelets to monocytes in a patient with hypogammaglobulinaemia.Scanning electron microscope observations on surface changes occurring in murine granulocytes and macrophages during maturation in soft agar cultures.The effect of alpha-interferon on thymidine, uridine, and leucine uptake and ultrastructure of peripheral blood mononuclear cells from multiple myeloma patients.Scanning electron microscope study of erythrocytes from patients with myopathy.The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis ratsRecent advances in interleukin-3 research: a review.Targeting the A3 adenosine receptor for glaucoma treatment (review).Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101.pH-induced platelet ultrastructural alterations. A possible mechanism for impaired platelet aggregation.Putative role of the adenosine A(3) receptor in the antiproliferative action of N (6)-(2-isopentenyl)adenosine.Drug-induced platelet surface alterations. A possible mechanism for impaired aggregation.
P50
Q28195442-FEAA8203-9123-4B05-9AF8-017F8F4D477AQ28367463-CF7511E5-357F-4402-BC5C-10E7C148D9D4Q30691758-DEB3BA1A-276A-472F-8FED-1AC29DEDE851Q31122323-E8D40FB0-9D3A-43EE-94E6-6D0825674484Q31132502-763178B4-D9AE-4B00-A085-6FA2BBEA1EBBQ31749645-21431318-AC57-445E-9227-552FBC0F0A3BQ33308049-CA46E1DF-EDBE-4829-B4A2-4CB8A614EC1CQ33355679-4D4AF25F-9E75-4BFE-95C0-07F78F27BE58Q33364820-A8FD245C-D346-4718-816C-1385F3E91E9AQ33490039-62734EDC-DC76-41F8-811E-F013095CEABEQ33494501-9D399D73-9950-4CBB-AE8D-9BEDE105D41CQ33494657-9AFBAAE7-0C04-4C1C-9F8F-6951D3C38CF2Q33543585-2F85A8D9-7011-4AF4-B08F-20EB30405317Q33636515-54C8A149-3FFD-4293-A5B4-499C71B04C52Q34124450-A8A0CD58-E69B-4EEE-8070-BA761766171AQ34412639-7AE0EF5C-17BB-4607-B470-335083066A9AQ34667844-1BD27775-DA10-460C-9BBA-5A8D5779333AQ34797617-F8DD70A3-76C0-4955-AD96-87486BDAB0A9Q34869700-BC9B3F26-8238-4683-BB5D-393A8A37E210Q35197058-1EB3F323-88C3-49F9-82F6-7E9E27468191Q35630047-0498B6B3-A1D8-4D38-AEEA-59DCEE5ADC3DQ35788500-54AFE1B2-DD68-42C9-999E-95BB54F51E99Q36327138-5504F4E7-8C17-4C6E-9739-7F46B5CE0C9EQ36484541-6D6848E1-7D13-4FD0-99E5-DE7A8765CAAFQ36485096-DDD2E6DF-9FC8-4347-9333-5F0A7F33ACB3Q36502119-A9286201-0428-4BA4-B896-B9C4667755E2Q36565624-7C9F18EB-92C6-4F83-8869-CF2F7404B91CQ36604022-EA8037EB-E22C-42A7-B996-DF280040D077Q36633771-35002B7F-A132-4BE5-A22D-9A5418239DE4Q36657530-7CE1A6AA-0D6B-46E8-A10E-A6A03CAB9A66Q36657972-45B7E967-021A-4A8C-9778-9945D4DD5842Q36781825-A0131C51-3610-4D2C-82DE-ED6AAE49E422Q36799680-FD4FA8B5-991B-4ECA-994E-56021D6AA647Q37180330-1232BBBC-A031-43D0-ABDA-2C441CA9B8C0Q37948042-BE1B9B91-4665-496C-B581-6BA17876089BQ38096824-F84712F3-01D5-4DC9-B261-B250399CE28DQ38602671-26029616-7115-42A9-A270-5BE518358C1CQ39255446-1D8F0D4D-9BBB-4020-A1CA-7012B8E44A14Q39393394-29B5A0E8-C9FD-4BAD-B96E-7E9945FDA648Q39654960-641ED53B-B45D-4EA9-943B-2C1D1F28A33B
P50
description
forsker
@nb
researcher
@en
name
Pnina Fishman
@da
Pnina Fishman
@de
Pnina Fishman
@en
Pnina Fishman
@es
Pnina Fishman
@fr
Pnina Fishman
@nb
Pnina Fishman
@nl
Pnina Fishman
@nn
Pnina Fishman
@sv
type
label
Pnina Fishman
@da
Pnina Fishman
@de
Pnina Fishman
@en
Pnina Fishman
@es
Pnina Fishman
@fr
Pnina Fishman
@nb
Pnina Fishman
@nl
Pnina Fishman
@nn
Pnina Fishman
@sv
prefLabel
Pnina Fishman
@da
Pnina Fishman
@de
Pnina Fishman
@en
Pnina Fishman
@es
Pnina Fishman
@fr
Pnina Fishman
@nb
Pnina Fishman
@nl
Pnina Fishman
@nn
Pnina Fishman
@sv
P214
P106
P21
P214
P31
P4012
P496
0000-0001-9641-6630
P735
P7859
viaf-310742916